UniSuper Management Pty Ltd Has $88.91 Million Stake in Colgate-Palmolive Company $CL

Key Points

• UniSuper Management Pty Ltd increased its stake in Colgate-Palmolive Company by 16.3% during the first quarter, owning approximately $88.91 million worth of shares.
• Colgate-Palmolive reported $0.92 earnings per share for the last quarter, exceeding analysts’ expectations of $0.89.
• The company announced a quarterly dividend of $0.52 per share, representing an annualized payout of $2.08 and a dividend yield of 2.4%.

UniSuper Management Pty Ltd raised its stake in Colgate-Palmolive Company (NYSE:CL - Free Report) by 16.3% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 948,910 shares of the company's stock after buying an additional 133,173 shares during the quarter. Colgate-Palmolive accounts for about 0.7% of UniSuper Management Pty Ltd's portfolio, making the stock its 23rd largest position. UniSuper Management Pty Ltd owned approximately 0.12% of Colgate-Palmolive worth $88,913,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also added to or reduced their stakes in the business. Richwood Investment Advisors LLC raised its stake in Colgate-Palmolive by 6.0% during the 1st quarter. Richwood Investment Advisors LLC now owns 4,132 shares of the company's stock worth $387,000 after buying an additional 235 shares during the period. Petrus Trust Company LTA acquired a new stake in Colgate-Palmolive during the 1st quarter worth $315,000. Plancorp LLC grew its position in shares of Colgate-Palmolive by 14.1% in the 1st quarter. Plancorp LLC now owns 10,856 shares of the company's stock valued at $1,017,000 after purchasing an additional 1,342 shares during the period. Nissay Asset Management Corp Japan ADV grew its position in shares of Colgate-Palmolive by 6.4% in the 1st quarter. Nissay Asset Management Corp Japan ADV now owns 166,621 shares of the company's stock valued at $15,612,000 after purchasing an additional 10,077 shares during the period. Finally, NatWest Group plc grew its position in shares of Colgate-Palmolive by 2.4% in the 1st quarter. NatWest Group plc now owns 62,097 shares of the company's stock valued at $5,818,000 after purchasing an additional 1,460 shares during the period. Institutional investors and hedge funds own 80.41% of the company's stock.

Colgate-Palmolive Price Performance

NYSE:CL opened at $85.13 on Friday. The company has a debt-to-equity ratio of 6.79, a quick ratio of 0.57 and a current ratio of 0.89. The stock's 50-day simple moving average is $86.74 and its 200 day simple moving average is $89.76. The company has a market cap of $68.80 billion, a P/E ratio of 23.91, a P/E/G ratio of 4.43 and a beta of 0.35. Colgate-Palmolive Company has a 52-week low of $82.40 and a 52-week high of $109.04.

Colgate-Palmolive (NYSE:CL - Get Free Report) last released its earnings results on Friday, August 1st. The company reported $0.92 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.89 by $0.03. The business had revenue of $5.11 billion for the quarter, compared to the consensus estimate of $5.03 billion. Colgate-Palmolive had a return on equity of 377.63% and a net margin of 14.55%.Colgate-Palmolive's quarterly revenue was up 1.0% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.91 earnings per share. As a group, sell-side analysts forecast that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Friday, July 18th were given a $0.52 dividend. The ex-dividend date of this dividend was Friday, July 18th. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.4%. Colgate-Palmolive's payout ratio is currently 58.43%.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on CL. Citigroup decreased their price objective on Colgate-Palmolive from $108.00 to $105.00 and set a "buy" rating for the company in a research report on Monday, August 4th. Morgan Stanley decreased their price objective on Colgate-Palmolive from $104.00 to $96.00 and set an "overweight" rating for the company in a research report on Monday, August 4th. Wells Fargo & Company dropped their price target on Colgate-Palmolive from $88.00 to $83.00 and set an "underweight" rating on the stock in a research note on Monday, August 4th. UBS Group dropped their price target on Colgate-Palmolive from $109.00 to $106.00 and set a "buy" rating on the stock in a research note on Thursday, July 17th. Finally, Barclays lifted their price target on Colgate-Palmolive from $86.00 to $87.00 and gave the company an "equal weight" rating in a research note on Tuesday, July 15th. Seven analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average price target of $98.92.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.